power of combination
Territories
Our Group believe that synargy and harmony with strong partner will last more than go alone, this is why we establish a well presence in several territories to enhance our distribution revenues, to reach to right customer.
Local subsidiaries with leading local players has yielded expontianl sales growth
SinoEast
- NMPA
- Promotion
- Pre-Sales
- Medical Tourism
- Mini Market Testing
SinoScience Hainan
- NMPA
- Promotion
- Pre-Sales
- Medical Tourism
- Mini Market Testing
SinoKar
- KOL’s, CRO’s
- Capitals
- Partnerships
- Market Analysis
Royal Bridge
- HQ
- South-East Asian Pivot
- Due Diligence
- Partnerships
deep understanding
chinese biomedical industry
Over the past decades, the Chinese Medical industry kept proliferating, getting the attention of various players worldwide. With an annual growth rate of around 20% since 2015, the industry has consistently outpaced worldwide growth.
When manufacturer decided to enter the Chinese market three broad ways exist: set up a local team, transfer the production by using a local OEM or purely imports.
Because each of these solutions presents pros & cons, our pipeline was built to best fit with the largest company’s profiles.
Our solution is the fruit of numerous business conversations with western companies that share their apprehensions, interrogations and more generally their experiences related to Chinese market entrance.
Hence, we propose a tailored-made solution that ultimately combines the overmentioned three major routes – importation, local team and OEM partnership.
